86A3B258-151F-468C-BD5C-58AB2A6BFD9C13 ERA IB: Investigating NOvel VAluable bio-Therapeutics and Expression systemsResearch GrantBB/M000699/12512EF1C-401B-4222-9869-A770D4C5FAC7BBSRCINCOME_ACTUAL343940654ED905-BF15-4032-A5D1-4E3D4BCCFDEEThe effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv.Biotechnology letters55752cb758cf90c94a84ba3467b80a95Gourbatsi E2018-01-01http://dx.doi.org/10.1007/s10529-017-2443-x28939995http://ukpmc.ac.uk/abstract/MED/289399950141-5492http://europepmc.org/abstract/MED/28939995401Journal Article/Review5c810a6728c623.85819283